Last reviewed · How we verify
Adult Gonococcal Conjunctivitis
Approved treatments
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Rocephin · Generic (originally Roche)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Adult Gonococcal Conjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Adult Gonococcal Conjunctivitis treatment landscape brief
- Adult Gonococcal Conjunctivitis treatment updates RSS
Frequently asked questions about Adult Gonococcal Conjunctivitis
What drugs treat Adult Gonococcal Conjunctivitis?
Tracked treatments include Ceftriaxon, Rocephin.
What is the treatment for Adult Gonococcal Conjunctivitis?
Standard treatment for Adult Gonococcal Conjunctivitis includes Ceftriaxon, Rocephin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Adult Gonococcal Conjunctivitis patent cliff · Adult Gonococcal Conjunctivitis CI report
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Rocephin · Generic (originally Roche)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing